Chitosan-Based Nanoparticles as Carriers for Drug Delivery and Biomedical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 523
Special Issue Editors
Interests: nanoparticles; chitosan; drug delivery
Interests: nanotechnology-based systems; bioadhesive systems; quality control
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Chitosan is a promising biomaterial used in the development of different types of health technologies. Due to its mucoadhesive and cell membrane modulating properties, nanoparticles produced from chitosan are extensively researched as an alternative carrier system for different routes of administration. Fundamental and technological research on chitosan nanoparticles has evolved, forming an extensive repertoire of knowledge about the mechanisms of formation and action of this system, as well as problems relating to toxicology, regulatory and scaling difficulties. Therefore, this Special Issue is dedicated to the publication of original articles and reviews focused on the science and technology of chitosan-based nanoparticles for drug delivery and other biomedical applications. Research works that provide updates on the scientific foundations that guide the formation of chitosan nanoparticles and the main mechanisms of biological interaction are welcome. Furthermore, equally relevant are studies that aim to further advance the technological development of chitosan nanoparticles as a platform for treating different types of diseases. The relevant topics include pre-formulation studies; questions about production and scale-up; problems relating to quality control, stability studies and regulatory systems; new applications; and anti-cancer, anti-inflammatory and nanotoxicological effects.
Dr. Aline Martins dos Santos
Dr. Leonardo Miziara Barboza Ferreira
Dr. Eleonora Maretti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chitosan
- nanoparticles
- pre-formulation
- drug delivery
- anti-cancer
- anti-inflammatory
- biomedical applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
